News
NEC Laboratories Europe and Data-Driven.AI are collaborating to advance medical diagnoses with the use of artificial intelligence (AI) and machine learning (ML).
Carmat has secured conditional approval from the FDA to commence the second cohort of its EFS in the US with the Aeson artificial heart.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback